Search Results - "Mariana Chávez-MacGregor"

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry by Brewster, Abenaa M, Dr, Chavez-MacGregor, Mariana, MD, Brown, Powel, Prof

“…Summary Breast cancer incidence is increasing worldwide, and breast cancer-related mortality is highest in women of African ancestry, who are more likely to…”
Get full text

Adjuvant tamoxifen adherence in men with early‐stage breast cancer by Oke, Oluchi, Niu, Jiangong, Chavez‐MacGregor, Mariana, Zhao, Hui, Giordano, Sharon H.

“…Background Most breast cancers (BCs) in men are hormone receptor–positive. Adjuvant tamoxifen is part of the standard treatment of these patients. Small,…”
Get full text

Survival in older women with early stage breast cancer receiving low‐dose bisphosphonates or denosumab by Suarez‐Almazor, Maria E., Herrera, Raul, Lei, Xiudong, Chavez‐MacGregor, Mariana, Zhao, Hui, Giordano, Sharon H.

“…Background Bisphosphonates and denosumab, as adjuvant therapy in breast cancer, have been associated in some studies with improved cancer outcomes. The…”
Get full text

Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population‐based study by Rauh‐Hain, J. Alejandro, Zubizarreta, Jose, Nitecki, Roni, Melamed, Alexander, Fu, Shuangshuang, Jorgensen, Kirsten, Brady, Paula C., Baker, Valerie L., Chavez‐MacGregor, Mariana, Giordano, Sharon H., Keating, Nancy L.

“…Background This study sought to determine the impact of pregnancy or assisted reproductive technologies (ART) on breast‐cancer‐specific survival among breast…”
Get full text

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer by Basho, Reva K., Yam, Clinton, Gilcrease, Michael, Murthy, Rashmi K., Helgason, Thorunn, Karp, Daniel D., Meric‐Bernstam, Funda, Hess, Kenneth R., Valero, Vicente, Albarracin, Constance, Litton, Jennifer K., Chavez‐MacGregor, Mariana, Hong, David, Kurzrock, Razelle, Hortobagyi, Gabriel N., Janku, Filip, Moulder, Stacy L.

“…Background Triple‐negative breast cancer (TNBC) is a heterogeneous disease with subtypes having different “targetable” molecular aberrations. Metaplastic…”
Get full text

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients by Rosenstock, Aron S., Niu, Jiangong, Giordano, Sharon H., Zhao, Hui, Wolff, Antonio C., Chavez‐MacGregor, Mariana

“…BACKGROUND Chemotherapy for early breast cancer is associated with a small risk of developing myelodysplastic syndrome (MDS) and/or acute myeloid leukemia…”
Get full text

Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ by Zhao, Hui, Hei, Nainan, Wu, Yiling, Chan, Winston, Lei, Xiudong, Cameron, Carrie, Chang, Shine, Chavez‐MacGregor, Mariana, Giordano, Sharon H.

“…BACKGROUND The National Surgical Adjuvant Breast and Bowel Project B35 and International Breast Cancer Intervention Studies II Ductal Carcinoma In Situ trials…”
Get full text

Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer by Kehl, Kenneth L., Niu, Jiangong, Chavez‐MacGregor, Mariana, Giordano, Sharon H.

“…Background Older patients with cancer are at risk for increased side effects of treatment. Our goal was to inform treatment for older patients by analyzing the…”
Get full text

Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms by Cacho‐Díaz, Bernardo, Salmerón‐Moreno, Karen, Alvarez‐Alvarez, Alejandra, Mendoza‐Olivas, Laura Georgina, Alvarado‐Miranda, Alberto, Villarreal‐Garza, Cynthia, Reynoso‐Noverón, Nancy, Chávez‐MacGregor, Mariana, Meneses‐García, Antelmo Abelardo

“…Background The current study was performed to identify factors that are present at the time of breast cancer (BC) diagnosis that are associated with a higher…”
Get full text

Delayed initiation of adjuvant chemotherapy in older women with breast cancer by Smith‐Graziani, Demetria, Lei, Xiudong, Giordano, Sharon H., Zhao, Hui, Karuturi, Meghan, Chavez‐MacGregor, Mariana

“…Background Adjuvant chemotherapy benefits early‐stage breast cancer (BC) patients. Older women receive guideline‐adherent treatment less frequently and…”
Get full text

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials by Chavez‐MacGregor, Mariana, Unger, Joseph M., Moseley, Anna, Ramsey, Scott D., Hershman, Dawn L.

“…BACKGROUND Racial disparities in cancer outcomes have been described. To the authors' knowledge, it remains unclear whether patients of Hispanic ethnicity have…”
Get full text

Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment by Adesoye, Taiwo, Liao, Kai-Ping, Peterson, Susan, Li, Liang, Zorzi, Daria, Holmes, Holly M, Chavez-MacGregor, Mariana, Giordano, Sharon H

“…Little is known about long-term treatment-related symptoms in older breast cancer survivors. We characterized long-term patient-reported symptoms and examined…”
Get full text

Best of the year: Advanced breast cancer in 2023 by Schlam, Ilana, Chavez-MacGregor, Mariana

“…•This article reviews some of the most clinically relevant data related to metastatic breast cancer presented during 2023.•Elacestrant (oral SERD) was approved…”
Get full text

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update by Allison, Kimberly H, Hammond, M Elizabeth H, Dowsett, Mitchell, McKernin, Shannon E, Carey, Lisa A, Fitzgibbons, Patrick L, Hayes, Daniel F, Lakhani, Sunil R, Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M, Regan, Meredith M, Rimm, David L, Symmans, W Fraser, Torlakovic, Emina E, Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F, McShane, Lisa M, Wolff, Antonio C

“…To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR)…”
Get full text

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update by Allison, Kimberly H, Hammond, M Elizabeth H, Dowsett, Mitchell, McKernin, Shannon E, Carey, Lisa A, Fitzgibbons, Patrick L, Hayes, Daniel F, Lakhani, Sunil R, Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M, Regan, Meredith M, Rimm, David L, Symmans, W Fraser, Torlakovic, Emina E, Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F, McShane, Lisa M, Wolff, Antonio C

“…To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen receptor (ER) and progesterone receptor…”
Get full text

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System by Chavez‐MacGregor, Mariana, Mittendorf, Elizabeth A., Clarke, Christina A., Lichtensztajn, Daphne Y., Hunt, Kelly K., Giordano, Sharon H.

“…Background The American Joint Committee on Cancer (AJCC) breast cancer staging system provides important prognostic information. The recently published eighth…”
Get full text

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation by Xing, Yan, Lin, Nancy U, Maurer, Matthew A, Chen, Huiqin, Mahvash, Armeen, Sahin, Aysegul, Akcakanat, Argun, Li, Yisheng, Abramson, Vandana, Litton, Jennifer, Chavez-MacGregor, Mariana, Valero, Vicente, Piha-Paul, Sarina A, Hong, David, Do, Kim-Anh, Tarco, Emily, Riall, Dianna, Eterovic, Agda Karina, Wulf, Gerburg M, Cantley, Lewis C, Mills, Gordon B, Doyle, L Austin, Winer, Eric, Hortobagyi, Gabriel N, Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda

“…The PI3K/AKT pathway is activated through PIK3CA or AKT1 mutations and PTEN loss in breast cancer. We conducted a phase II trial with an allosteric AKT…”
Get full text

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update by Denduluri, Neelima, Chavez-MacGregor, Mariana, Telli, Melinda L, Eisen, Andrea, Graff, Stephanie L, Hassett, Michael J, Holloway, Jamie N, Hurria, Arti, King, Tari A, Lyman, Gary H, Partridge, Ann H, Somerfield, Mark R, Trudeau, Maureen E, Wolff, Antonio C, Giordano, Sharon H

“…Purpose To update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy…”
Get full text

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer by CHAVEZ-MACGREGOR, Mariana, NING ZHANG, BUCHHOLZ, Thomas A, YUFENG ZHANG, JIANGONG NIU, ELTING, Linda G, SMITH, Benjamin D, HORTOBAGYI, Gabriel N, GIORDANO, Sharon H

“…The use of trastuzumab in the adjuvant setting improves outcomes but is associated with cardiotoxicity manifested as congestive heart failure (CHF). The rates…”
Get full text

Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer by Sharma, Manvi, Duan, Zhigang, Zhao, Hui, Giordano, Sharon H., Chavez‐MacGregor, Mariana

“…Background There is limited literature on patterns of everolimus use and subsequent hospitalizations and emergency room (ER) visits in real‐world clinical…”
Get full text